In a trading update released Thursday morning, Inspecs Group, the designer, manufacturer, and distributor of eyewear frames, gave a lift to shareholders.
The AIM-quoted company said that following its strong trading performance delivered in the first half of the year, it has continued into the third quarter.
Inspecs revealed that unaudited revenues for the 9 months to 30 September came in at $185m. The revenue for the six months to 30 June was $125.7m.
However, the company stated that it remains cautious of headwinds in the fourth quarter as COVID-19 continues to impact the global supply chain.
“The Group remains confident in its full year outlook and notes the 2022 order book is in line with management's expectations,” said Inspecs.
The news has seen Inspecs' stock price climb 2.3% to 400p per share. For 2021 it is up over 20%, while in the last 12 months, it has gained just shy of 125%.
Inspecs shares are traded on the London stock exchange's AIM market (the alternative investment market), which is the submarket specifically for smaller companies. AIM stocks are attractive to investors as they have tax advantages and smaller companies have the potential to benefit from rapid growth. But are SPEC shares the best buy? Our stock market analysts regularly review the market and share their picks for high growth companies
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .
Sam is a trader and lead stock market writer at AskTraders. After starting his career in the forex market, Sam now focuses on stocks, specifically consumer staples.